☰

Lilla Reiniger, Dr. - Publications

Affiliations: 
2007 Semmelweis Egyetem, Hungary 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Balogh A, Reiniger L, Hetey S, Kiraly P, Toth E, Karaszi K, Juhasz K, Gelencser Z, Zvara A, Szilagyi A, Puskas LG, Matko J, Papp Z, Kovalszky I, Juhasz C, et al. Decreased Expression of in Gliomas is Associated with the Activation of Tumor Pathways and Shorter Patient Survival. International Journal of Molecular Sciences. 21. PMID 32796700 DOI: 10.3390/Ijms21165762  0.401
2020 Tanjore Ramanathan J, Lehtipuro S, Sihto H, Tóvári J, Reiniger L, Téglási V, Moldvay J, Nykter M, Haapasalo H, Le Joncour V, Laakkonen P. Prostate-specific membrane antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to the brain. Journal of Cellular and Molecular Medicine. PMID 32390293 DOI: 10.1111/Jcmm.15350  0.36
2019 Bödör C, Alpár D, Marosvári D, Galik B, Rajnai H, Bátai B, Nagy Á, Kajtár B, Burján A, Deák B, Schneider T, Alizadeh H, Matolcsy A, Brandner S, Storhoff J, ... ... Reiniger L, et al. Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma. Journal of Neuropathology and Experimental Neurology. PMID 31886867 DOI: 10.1093/Jnen/Nlz125  0.442
2019 Tőkés AM, Rusz O, Cserni G, Tóth E, Rubovszky G, Tőkés T, Vízkeleti L, Reiniger L, Kószó R, Kahán Z, Kulka J, Donia M, Vörös A, Szallasi Z. Influence of mutagenic versus non-mutagenic pre-operative chemotherapy on the immune infiltration of residual breast cancer. Acta Oncologica (Stockholm, Sweden). 1-9. PMID 31271119 DOI: 10.1080/0284186X.2019.1633015  0.339
2019 Gángó A, Alpár D, Galik B, Marosvári D, Kiss R, Fésüs V, Aczél D, Eyüpoglu E, Nagy N, Nagy Á, Krizsán S, Reiniger L, Farkas P, Kozma A, Ádám E, et al. Dissection of Subclonal Evolution by Temporal Mutation Profiling in Chronic Lymphocytic Leukemia Patients Treated With Ibrutinib. International Journal of Cancer. PMID 31180577 DOI: 10.1016/J.Clml.2019.07.214  0.37
2019 Németh E, Krzystanek M, Reiniger L, Ribli D, Pipek O, Sztupinszki Z, Glasz T, Csabai I, Moldvay J, Szallasi Z, Szüts D. The genomic imprint of cancer therapies helps timing the formation of metastases. International Journal of Cancer. PMID 30694556 DOI: 10.1002/Ijc.32159  0.331
2019 Haberler C, Reiniger L, Rajnai H, Kalev O, Gelpi E, Tamesberger M, Pietsch T. Case of the month 1-2019: CNS high-grade neuroepithelial tumor with alteration. Clinical Neuropathology. 38: 4-7. PMID 30526817 DOI: 10.5414/Np301162  0.336
2018 Mózes R, Gángó A, Sulák A, Vida L, Reiniger L, Timár B, Krenács T, Alizadeh H, Masszi T, Gaál-Weisinger J, Demeter J, Csomor J, Matolcsy A, Kajtár B, Bödör C. Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasms. Pathology. PMID 30606612 DOI: 10.1016/J.Pathol.2018.11.007  0.326
2018 Szurián K, Csala I, Marosvári D, Rajnai H, Dezső K, Bödör C, Piurkó V, Matolcsy A, Reiniger L. EZH2 is upregulated in the proliferation centers of CLL/SLL lymph nodes. Experimental and Molecular Pathology. 105: 161-165. PMID 30031020 DOI: 10.1016/J.Yexmp.2018.07.009  0.389
2018 Németh K, Szücs N, Czirják S, Reiniger L, Szabó B, Barna G, Karászi K, Igaz P, Zivkovic V, Korbonits M, Patócs A, Butz H. Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas. Oncotarget. 9: 29180-29192. PMID 30018744 DOI: 10.18632/Oncotarget.25650  0.303
2018 Diossy M, Reiniger L, Sztupinszki Z, Krzystanek M, Timms KM, Neff C, Solimeno C, Pruss D, Eklund AC, Tóth E, Kiss O, Rusz O, Cserni G, Zombori T, Székely B, et al. Breast cancer brain metastases show increased levels of genomic aberration based homologous recombination deficiency scores relative to their corresponding primary tumors. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 29917049 DOI: 10.1093/Annonc/Mdy216  0.311
2018 Marosvári D, Nagy N, Kriston C, Deák B, Hajdu M, Bödör C, Csala I, Bagó AG, Szállási Z, Sebestyén A, Reiniger L. Discrepancy Between Low Levels of mTOR Activity and High Levels of P-S6 in Primary Central Nervous System Lymphoma May Be Explained by PAS Domain-Containing Serine/Threonine-Protein Kinase-Mediated Phosphorylation. Journal of Neuropathology and Experimental Neurology. PMID 29361117 DOI: 10.1093/Jnen/Nlx121  0.311
2016 Virág J, Haberler C, Baksa G, Piurkó V, Hegedüs Z, Reiniger L, Bálint K, Chocholous M, Kiss A, Lotz G, Glasz T, Schaff Z, Garami M, Hegedűs B. Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases. Pathology Oncology Research : Por. PMID 27395057 DOI: 10.1007/S12253-016-0084-3  0.399
2016 Marosvári D, Alpár D, Király AP, Rajnai H, Reiniger L, Bödör C. [The genetic landscape of chronic lymphocytic leukemia]. Magyar Onkologia. 60: 118-25. PMID 27275638  0.303
2016 Bödör C, Reiniger L. Catalog of genetic progression of human cancers: non-Hodgkin lymphoma. Cancer Metastasis Reviews. 35: 109-27. PMID 26957091 DOI: 10.1007/S10555-016-9608-2  0.379
2015 Kriston C, Bödör C, Szenthe K, Bánáti F, Bánkuti B, Csernus B, Reiniger L, Csomor J, Matolcsy A, Barna G. Low CD23 expression correlates with high CD38 expression and the presence of trisomy 12 in CLL. Hematological Oncology. PMID 26119874 DOI: 10.1002/Hon.2244  0.308
2012 Balogh ZB, Reiniger L, Rajnai H, Csomor J, Szepesi A, Balogh A, Deak L, Gagyi E, Bodor C, Matolcsy A. P1.17 High Rate of Genetic Abnormalities of Neoplastic Cells in Pseudofollicles of Cll Annals of Oncology. 23. DOI: 10.1016/S0923-7534(20)31308-9  0.676
2011 Balogh Z, Reiniger L, Rajnai H, Csomor J, Szepesi A, Balogh A, Deák L, Gagyi E, Bödör C, Matolcsy A. High rate of neoplastic cells with genetic abnormalities in proliferation centers of chronic lymphocytic leukemia. Leukemia & Lymphoma. 52: 1080-4. PMID 21417824 DOI: 10.3109/10428194.2011.555889  0.678
2011 Barna G, Mihalik R, Timár B, Tömböl J, Csende Z, Sebestyén A, Bödör C, Csernus B, Reiniger L, Peták I, Matolcsy A. ROR1 expression is not a unique marker of CLL. Hematological Oncology. 29: 17-21. PMID 20597086 DOI: 10.1002/Hon.948  0.435
2008 Gagyi E, Balogh Z, Bödör C, Timár B, Reiniger L, Deák L, Csomor J, Csernus B, Szepesi A, Matolcsy A. Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression. Haematologica. 93: 1822-8. PMID 18945749 DOI: 10.3324/Haematol.13239  0.677
2008 Csomor J, Bognár A, Benedek S, Sinkó J, Fekete S, Krenács L, Matolcsy A, Reiniger L. Rare provisional entity: primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma in a young woman. Journal of Clinical Pathology. 61: 770-2. PMID 18505891 DOI: 10.1136/Jcp.2007.054585  0.35
2007 Balogh Z, Reiniger L, Deák L, Bödör C, Csomor J, Szepesi A, Gagyi E, Kopper L, Matolcsy A. IgVH gene mutation status and genomic imbalances in chronic lymphocytic leukaemia with increased prolymphocytes (CLL/PL). Hematological Oncology. 25: 90-5. PMID 17410523 DOI: 10.1002/Hon.812  0.685
2006 Rajnai H, Bödör C, Reiniger L, Timár B, Csernus B, Szepesi A, Csomor J, Matolcsy A. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation]. Orvosi Hetilap. 147: 2175-9. PMID 17402211  0.638
2006 Reiniger L, Bödör C, Bognár A, Balogh Z, Csomor J, Szepesi A, Kopper L, Matolcsy A. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation. Leukemia. 20: 1089-95. PMID 16541139 DOI: 10.1038/Sj.Leu.2404183  0.688
2005 Bognár A, Csernus B, Bödör C, Reiniger L, Szepesi A, Tóth E, Kopper L, Matolcsy A. Clonal selection in the bone marrow involvement of follicular lymphoma. Leukemia. 19: 1656-62. PMID 15973453 DOI: 10.1038/Sj.Leu.2403844  0.668
2005 Bödör C, Bognár A, Reiniger L, Szepesi A, Tóth E, Kopper L, Matolcsy A. Aberrant somatic hypermutation and expression of activation-induced cytidine deaminase mRNA in mediastinal large B-cell lymphoma. British Journal of Haematology. 129: 373-6. PMID 15842661 DOI: 10.1111/J.1365-2141.2005.05454.X  0.685
Show low-probability matches.